This page tracks congressional stock trading activity in InMode Ltd. (INMD) in the Healthcare sector. Disclosed Capitol has indexed 3 disclosed congressional trades involving INMD. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of April 2022 — Disclosed Capitol has tracked 3 disclosed congressional trades in InMode Ltd. (INMD) — 1 buys with no recorded sells — led by Tom Rice (R).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Apr 13, 2022 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Feb 24, 2020 | Tom Rice | R | Unknown | $1,001 - $15,000 |
| Nov 15, 2019 | Tom Rice | R | Buy | $1,001 - $15,000 |
Across the 3 disclosed congressional trades in InMode Ltd. (INMD), members of Congress have reported 1 buy and 0 sells. The average 30-day alpha vs. the S&P 500 is -15.65%.
As of August 2026, corporate insiders at InMode Ltd. have filed 4 SEC Form 4 transactions in INMD over the past 12 months.
| Date | Insider | Action | Value |
|---|---|---|---|
| 2026-08-04 | Itzkovich Moshe — Chief Financial Officer | Award | — |
| 2026-07-30 | Kenneth Nadav — Director | Award | — |
| 2026-07-30 | Nass Shlomo — Director | Award | — |
| 2026-07-30 | Ron Hadar — Director | Award | — |
Insider transactions are parsed from SEC Form 4 filings and shown alongside the congressional trades above. Institutional 13F positions are tracked separately on the institutional holdings page.